Ricardo Cabello
A5103272744- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Liver Diseases and Immunity
- Hepatitis B Virus Studies
- Pediatric Hepatobiliary Diseases and Treatments
- Pancreatitis Pathology and Treatment
- Amoebic Infections and Treatments
- Abdominal Surgery and Complications
- Organ Transplantation Techniques and Outcomes
University of Pittsburgh
2018-2023
University of Pittsburgh Medical Center
2019
Mount Sinai Beth Israel
2016
BACKGROUNDGiant cell hepatitis in the adult population remains very poorly defined with only 100 case reports published literature over last three decades. AIMTo present our center's experience an attempt to learn about predisposing factors, outcomes and efficacy of proposed therapeutic interventions for giant hepatitis.
INTRODUCTION: Hospitalized patients with cirrhosis can develop respiratory failure (RF), which is associated a poor prognosis, but predisposing factors are unclear. METHODS: We prospectively enrolled multicenter North American inpatient cohort and collected admission in-hospital data (grading per European Association for the Study of Liver-Chronic Liver Failure scoring system, acute kidney injury [AKI], infections [admission/nosocomial], albumin use) in an era when terlipressin was not...
Introduction: We aim to prove that FibroScan is a better predictor of advanced liver disease than Fibro-Sure as assessed by clinical and laboratory findings Methods: In this retrospective study, the 198 patients selected had confirmed HCV infection, age>40 years assessment fibrosis with FibroSure discordant projected METAVIR scores. Patients were divided in 2 groups, Fibroscan group included whose scores higher when measured FibroSure. The FibroScan. Patient demographic characteristics...